A PYMNTS Company

The Intersection of Antitrust, Patents, and FDA Law: The TriCor Litigation

BY | March 26, 2009

This article is part of a Chronicle. See more from this Chronicle Richard Epstein, Mar 26, 2009 The purpose of this brief essay is to address the interconnections among three…

This article is part of a Chronicle. See more from this Chronicle

Richard Epstein, Mar 26, 2009

The purpose of this brief essay is to address the interconnections among three important areas of law: antitrust, patents, and FDA regulation. Each of these presents formidable difficulties in its own right. The integration of any two areas of law is always vexed. The interconnections among three different bodies of law of vital relevance to the pharmaceutical industry present a still more formidable

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 142.93.75.231

Please verify email or join us to access premium content!